2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with imatinib mesylate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, GC; Fung, KL; Liang, RH | 1 |
1 other study(ies) available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and imatinib mesylate
| Article | Year |
|---|---|
Vincristine but not imatinib could suppress mesenchymal niche's support to lymphoid leukemic cells.
Topics: Antineoplastic Agents; Asparaginase; Benzamides; Bone Marrow Cells; Coculture Techniques; Drug Screening Assays, Antitumor; Humans; Imatinib Mesylate; Inhibitory Concentration 50; Leukemia, Lymphoid; Mesenchymal Stem Cells; Mesoderm; Models, Biological; Piperazines; Pyrimidines; Stromal Cells; Tetrazolium Salts; Vincristine | 2010 |